Considering that one of the roots of metabolic disease is abnormal ABC transporter-related lipid metabolism, microRNA (miRNA) therapy has been identified as a promising strategy to radically treat metabolic diseases. The gene discussed is ABCG2; the disease is Other metabolic disease.